Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1982 2
1983 4
1984 2
1985 4
1986 4
1987 5
1988 1
1989 5
1990 5
1991 4
1992 6
1993 5
1994 3
1995 2
1996 9
1997 2
1998 4
1999 6
2000 4
2001 3
2002 5
2003 8
2004 13
2005 15
2006 24
2007 20
2008 12
2009 20
2010 32
2011 29
2012 29
2013 34
2014 27
2015 35
2016 26
2017 34
2018 33
2019 30
2020 43
2021 41
2022 34
2023 16
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

583 results

Results by year

Filters applied: . Clear all
Page 1
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Clinical Trial.
Euglycemic Ketoacidosis.
Bonora BM, Avogaro A, Fadini GP. Bonora BM, et al. Among authors: avogaro a. Curr Diab Rep. 2020 May 19;20(7):25. doi: 10.1007/s11892-020-01307-x. Curr Diab Rep. 2020. PMID: 32424730 Review.
A perspective on NETosis in diabetes and cardiometabolic disorders.
Fadini GP, Menegazzo L, Scattolini V, Gintoli M, Albiero M, Avogaro A. Fadini GP, et al. Among authors: avogaro a. Nutr Metab Cardiovasc Dis. 2016 Jan;26(1):1-8. doi: 10.1016/j.numecd.2015.11.008. Epub 2015 Nov 25. Nutr Metab Cardiovasc Dis. 2016. PMID: 26719220 Review.
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence.
Bonora BM, Avogaro A, Fadini GP. Bonora BM, et al. Among authors: avogaro a. Diabetes Metab Syndr Obes. 2020 Jan 21;13:161-174. doi: 10.2147/DMSO.S233538. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32021362 Free PMC article. Review.
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Among authors: avogaro a. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
583 results